CRISPR-Cas13: A new technology for the rapid detection of pathogenic microorganisms

被引：15
|
作者：
Huang, Zhanchao [1 ]
Fang, Jianhua [1 ]
Zhou, Min [2 ]
Gong, Zhenghua [2 ]
Xiang, Tianxin [1 ]
机构：
[1] Nanchang Univ, Med Ctr Major Publ Hlth Events Jiangxi Prov, Affiliated Hosp 1, Nanchang, Peoples R China
[2] Jiangxi Zhongke Yanyuan Biotechnol Co Ltd, Nanchang, Peoples R China
来源：
FRONTIERS IN MICROBIOLOGY | 2022年 / 13卷
关键词：
CRISPR; Cas13; rapid detection; pathogenic; microorganisms; MEDIATED ISOTHERMAL AMPLIFICATION; NUCLEIC-ACID DETECTION; CAS SYSTEMS; DETECTION PLATFORM; WEST-AFRICA; EBOLA-VIRUS; RNA; DNA; CLASSIFICATION; EVOLUTION;
D O I：
10.3389/fmicb.2022.1011399
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Pathogenic microorganisms have major impacts on human lives. Rapid and sensitive diagnostic tools are urgently needed to facilitate the early treatment of microbial infections and the effective control of microbial transmission. CRISPR-Cas13 employs programmable RNA to produce a sensitive and specific method with high base resolution and thus to provide a novel tool for the rapid detection of microorganisms. The review aims to provide insights to spur further development by summarizing the characteristics of effectors of the CRISPR-Cas13 system and by describing the latest research into its application in the rapid detection of pathogenic microorganisms in combination with nucleic acid extraction, isothermal amplification, and product detection.
引用
收藏
页数：14
相关论文
共 50 条
  • [41] CRISPR-Cas13: Pioneering RNA Editing for Nucleic Acid Therapeutics
    Zhu, Guanglin
    Zhou, Xinzhi
    Wen, Mingzhang
    Qiao, Jianjun
    Li, Guo
    Yao, Yuan
    BIODESIGN RESEARCH, 2024, 6
  • [42] CRISPR-Cas13系统与活细胞RNA标记
    杨良中
    王洋
    陈玲玲
    生命的化学, 2020, 40 (01) : 1 - 7
  • [43] Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family
    Liu, Li
    Pei, De-Sheng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [44] Comparison of CRISPR-Cas13 RNA editing tools for inherited retinal disease
    Fry, Lewis E.
    McClements, Michelle E.
    MacLaren, Robert E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [45] Progress Toward Translating AAV. CRISPR-Cas13 Therapy for FSHD
    Rashnonejad, Afrooz
    Chermahini, Gholamhossein Amini
    Taylor, Noah K.
    Harper, Scott Q.
    MOLECULAR THERAPY, 2020, 28 (04) : 218 - 218
  • [46] Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment
    Zhou, Qianqian
    Chen, Yanhua
    Wang, Ruolei
    Jia, Fengjing
    He, Feng
    Yuan, Fuwen
    GENES & DISEASES, 2023, 10 (06) : 2414 - 2424
  • [47] Intrinsic RNA-targeting activity limits the applicability of CRISPR-Cas13
    Fei, Teng
    Li, Wei
    NATURE BIOMEDICAL ENGINEERING, 2024, 8 (02) : 116 - 117
  • [48] Rapid detection of pathogenic E. coli based on CRISPR Cas system
    Rathore, Pallavi
    Basnet, Ashesh
    Kilonzo-Nthenge, Agnes
    Dumenyo, Korsi
    Yadegari, Zeinab
    Taheri, Ali
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [49] Diagnostics of Infections Produced by the Plant Viruses TMV, TEV, and PVX with CRISPR-Cas12 and CRISPR-Cas13
    Marques, Maria-Carmen
    Sanchez-Vicente, Javier
    Ruiz, Rau'l
    Montagud-Martinez, Roser
    Marquez-Costa, Rosa
    Gomez, Gustavo
    Carbonell, Alberto
    Daros, Jose-Antonio
    Rodrigo, Guillermo
    ACS SYNTHETIC BIOLOGY, 2022, 11 (07): : 2384 - 2393
  • [50] Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing
    Fiflis, David
    Rey, Nicolas
    Venugopal-Lavanya, Harshitha
    Sewell, Beatrice
    Mitchell-Dick, Aaron
    Clements, Katie
    Milo, Sydney
    Benkert, Abigail
    Rosales, Alan
    Fergione, Sophia
    Asokan, Aravind
    NATURE COMMUNICATIONS, 2024, 15 (01)
12345